학술논문
917P - Clinical activity of vofatamab (V), an FGFR3 selective antibody in combination with pembrolizumab (P) in metastatic urothelial carcinoma (mUC), updated interim analysis of FIERCE-22
Document Type
Abstract
Author
Source
In Annals of Oncology October 2019 30 Supplement 5:v365-v365
Subject
Language
ISSN
0923-7534